Académique Documents
Professionnel Documents
Culture Documents
THALASSEMIA MAJOR
Presenter:
Supervisor:
dr. Rita Evalina, Sp.A(K)
PEDIATRIC DEPARTMENT
RSUP H ADAM MALIK MEDAN
INTRODUCTION
Until recently, autoimmune encephalitis was
restricted to the syndrome described as
paraneoplastic limbic encephalitis (LE), an
infrequent paraneoplastic neurological
syndrome (PNS) mainly associated with lung
cancer
These encephalitides are not as unusual as
previously believed. In a retrospective
analysis of encephalitis of unknown origin
admitted to an intensive care unit, 1% were
finally identified as autoimmune
EPIDEMIOLOGY
The overall incidence of the condition
is unknown
Higher incidence than viral
encephalitis
81% diagnosed in woman
Median age at 21 years
Over one-third are children
PATHOPHYSIOLOGY
Anti NMDA
receptor
Reduction of
NMDA
activity
Failure of
synapse
transmission
CLINICAL MANIFESTATION
1. Failure to thrive in early childhood
2. Anemia
3. Jaundice, gallstones
4. Hepatosplenomegaly, hypersplenism
5. Abnormal facies, prominence of malar
eminences, frontal bossing, depression of
bridge of nose, and exposure of upper central
teeth (Cooleys Face)
6. Growth retardation, delayed puberty
7. Leg ulcers
8. Skin bronzing
9
Thalassemia facies
DIAGNOSIS
DIFFERENTIAL DIAGNOSIS
MANAGEMENT
Hypertransfusion Protocol
Chelation Therapy
Splenectomy
Supportive care
Hematopoietic Stem Cell
Transplantation
Gene Therapy
COMPLICATIONS
PROGNOSTIC FACTOR
The prognosis depends on the type
and severity of thalassemia. As stated
above, the clinical course of
thalassemia varies greatly from mild or
even asymptomatic to severe and life
threatening.
CASE REPORT
Name : R
Age : 4 years 3 months 9 days
Sex : Male
Date of Admission : October, 3rd 2014
BIRTH HISTORY:
Spontaneous, normoterm ( 38 weeks), attended by
midwives, BW 3000 gram, BL 50 cm, cyanotic (-)
IMMUNIZATION HISTORY
Hepatitis B, BCG, DPT, polio and measles
vaccination were complete.
FEEDING HISTORY
From birth to 2 months : Breast milk only
From 2 months to 4 months : Formula milk only
From 4 months to 6 months : Formula milk and
rice porridge
From 6 months to 1 year 3 months : Rice porridge only
From 1 year 3 m months until : Family menu
HISTORY OF GROWTH AND
DEVELOPMENT
Sitting : 4 months
Crawling : 7 months
Standing: 12 months
Walking : 12 months
Localized status :
Head :
Eye: Conjunctiva palpebra inferior pale (+)
Right Eye : Pupil diameter 3 mm. Conjunctiva palpebra inferior pale (+). Icteric
sclera (-).Light reflex (+).
Left Eye : Pupil diameter 3 mm. Conjunctiva palpebra inferior pale (+).
Icteric sclera (-).Light reflex (+).
Face: within normal limit
Ear: within normal limit
Nose: within normal limit
Mouth: within normal limit
Neck :
Lymph node enlargement (-)
Thorax:
Symmetrical fusiformis, epigastrial chest retraction, HR: 80
bpm, regular, murmur (-). RR: 25x/i, regular,
rales (-)
Abdomen:
Soepel, normal peristaltic, liver was palpable 4 cm below
right costal arc , spleen was palpable schauffner : II
Extremities:
Pulse 80 bpm, regular, adequate pressure and volume,
warm, CRT < 3,
Urogenital:
Male, within normal limit.
Complete Blood Count (3rd October 2014)
Complete Blood Count
Hemoglobin 4,10 gr% 11,3 14,1 gr%
Hematocrite 12,2 % 37 41%
Erithrocyte 1,60 x 106 /mm3 4,40 4,48 x 106 /mm3
Leucocyte 5,54 x 103 /mm3 4,5 13,5 x 103 /mm3
Platelet 167.000 /mm3 217.000 497.000 /mm3
MCV 76,30 fl 81 95 fl
MCH 25,60 pg 25 29 pg
MCHC 33,6 gr% 29 31 gr%
RDW 19.60 % 11.6 14.8 %
Difftel
Neutrofil 42,80 37-80
Limfosit 44,80 20-40
Monosit 9,0 2-8
Eosinofil 2,70 1-6
Basofil 0,70 0-1
Neutrofil absolute 2,37 1,9-5,4
Limfosit absolute 2,48 3,7-10,7
Monositabsolute 0,50 0,3-0,8
Eosinofil absolute 0,15 0,2-0,5
Basofil absolute 0,04 0-0,1
Hemostatic Function
Test
Ferritin 1833,00 ng/mL Adult: 15 300
Child: 15 240
Iron (Fe) 118 mg/dL 61 - 157
TIBC 131 g/dL 112 346
Renal Function Test
Ureum 11.2 mg/dL < 50
Creatinine 0.22 mg/dL 0,31 0,42
Uric Acid 5,2 mg/dL < 7,0
Liver Function Test
Total Bilirubin 1,41 mg/dL <1
Direct Bilirubin 0,42 mg/dL 0 0,2
Alkaline Phospatase 87 U/L < 269
(ALP)
AST/SGOT 19 U/L < 38
ALT/SGPT 11 U/L < 41
Uric Acid 5,2 mg/dL < 7,0
Radiologic Imaging October 3rd 2014
Working Diagnosis:
-thalassemia major
Management:
Bed rest
Folic Acid 1 x 1 mg
Vitamine C 1 x 1 tab
Vitamine E 1 x 1 cap
Diet MB 1100 kcal with 24 grams protein
PRC Transfusion as needed
Transfussion requirement: Hb x 4 BW: (12 4,1) x 12 x 4 = 455,04 450
cc
Transfussion ability : 3 cc/kgBW: 3 x12 : 36 cc 50 cc
Diagnostic Planning:
Echocardiography
Follow Up 3rd July 2014
S Pale (+)
Head No deformities
Right Eye : Pupil diameter 3 mm. Conjunctiva
palpebrainferior pale (+).
Icteric sclera (-). Light reflex (+).
Left Eye : Pupil diameter 3 mm. Conjunctiva
palpebrainferior pale (+).
Icteric sclera (-). Light reflex (+).
P Management:
Bed rest
Folic Acid 1 x 1 mg
Vitamine C 1 x 1
Vitamine E 1 x 100 IU
Diet MB 1100 kcal with 24 grams protein
PRC Transfusion as needed (day 1)
Transfussion requirement: Hb x 4 BW: (12 4,1) x
12 x 4 = 455 cc 450 cc
Transfussion ability : 3 cc/kgBW: 3 x12 : 36 cc
50 cc
Diagnostic Planning:
- Echocardiography
Follow Up 4th July 2014
S Pale (+)
Head No deformities
Right Eye : Pupil diameter 3 mm. Conjunctiva
palpebrainferior pale (+).
Icteric sclera (-). Light reflex (+).
Left Eye : Pupil diameter 3 mm. Conjunctiva
palpebrainferior pale (+).
Icteric sclera (-). Light reflex (+).
P Management:
Bed rest
Folic Acid 1 x 1 mg
Vitamine C 1 x 1
Vitamine E 1 x 100 IU
Diet MB 1100 kcal with 24 grams protein
PRC Transfusion as needed (day 2)
175 cc ( has been done 50 cc from 450 cc needed)
Exjade 1 x 1 tab
Diagnostic Planning:
- Echocardiography
- Consul Pediatric Cardiologist, ophtalmologist, ENT,
pusyansus
Follow Up 5th July 2014
S Pale (+)
Head No deformities
Right Eye : Pupil diameter 3 mm. Conjunctiva
palpebrainferior pale (+).
Icteric sclera (-). Light reflex (+).
Left Eye : Pupil diameter 3 mm. Conjunctiva
palpebrainferior pale (+).
Icteric sclera (-). Light reflex (+).
P Management:
Bed rest
Folic Acid 1 x 1 mg
Vitamine C 1 x 1
Vitamine E 1 x 100 IU
Diet MB 1100 kcal with 24 grams protein
PRC Transfusion as needed (day 3) 150 cc ( has been
done 225 cc from 450 cc needed)
Desferal 600 mg/24 h/ iv
S Pale (+)
Head No deformities
Right Eye : Pupil diameter 3 mm. Conjunctiva
palpebrainferior pale (+).
Icteric sclera (-). Light reflex (+).
Left Eye : Pupil diameter 3 mm. Conjunctiva
palpebrainferior pale (+).
Icteric sclera (-). Light reflex (+).
P Management:
Bed rest
Folic Acid 1 x 1 mg
Vitamine C 1 x 1
Vitamine E 1 x 100 IU
Diet MB 1100 kcal with 24 grams protein
PRC Transfusion as needed (last day) 75 cc ( has
been done 375 cc from 450 cc needed)
Exjade 1x1 tab
Laboratorium result :
Imunodeficiency profile :
Anti HIV ( 3 Methods)
Anti HIV (rapid I) : non reaktif
Anti HIV (rapid II) : non reaktif
Anti HIV (rapid III) : non reaktif
Follow Up 7th July 2014
S Pale (-)
Head No deformities
Right Eye : Pupil diameter 3 mm. Conjunctiva
palpebrainferior pale (+).
Icteric sclera (-). Light reflex (+).
Left Eye : Pupil diameter 3 mm. Conjunctiva
palpebrainferior pale (+).
Icteric sclera (-). Light reflex (+).
P Management:
Bed rest
Folic Acid 1 x 1 mg
Vitamine C 1 x 1
Vitamine E 1 x 100 IU
Diet MB 1100 kcal with 24 grams protein
Desferal 600 mg / 24 h / iv
Echocardiography result:
Left sided erlagement
Minimal PE
Good function
Laboratorium result :
CBC :
Hb : 13,10 g%
Ht : 34,9 %
Ery : 4,34 x 106/mm3
Leu : 4850/mm3
Trom : 444.000/mm3
MCV/MCH/MCHC/RDW: 80,4/30,2/37,5/17,5
E/B/N/L/M : 1/0,6/59,9/317,4/5
Follow Up 8th July 2014
S Pale (-)
Head No deformities
Right Eye : Pupil diameter 3 mm. Conjunctiva
palpebrainferior pale (+).
Icteric sclera (-). Light reflex (+).
Left Eye : Pupil diameter 3 mm. Conjunctiva
palpebrainferior pale (+).
Icteric sclera (-). Light reflex (+).
P Management:
Bed rest
Folic Acid 1 x 1 mg
Vitamine C 1 x 1
Vitamine E 1 x 100 IU
Diet MB 1100 kcal with 24 grams protein
Exjade 1x1 tab (30 days)
Planning:
Control to Pediatric Hemato-oncology unit
HAM General Hospital
DISCUSSION AND
SUMMARY
SUMMARY
It has been reported a case of a boy, 4 years old with
Thalassemia Major. The diagnosis was established based on
anamnesis, clinical sign, symptoms, and physical examination.
The prognostic of this patient was not good due to continuous
transfusion. This patient should remain controlled as an
outpatient to prevent complication of continuous transfussion.
This patient also need chelation to reduce the accumulation of
iron, along with other nutrient (calcium, vitamin D, folic acid,
trace mineral (copper, zinc, and selenium) and antioxidant
vitamins (E and C).
Thankyou
!